- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 263/60 - Naphthoxazoles; Hydrogenated naphthoxazoles
Patent holdings for IPC class C07D 263/60
Total number of patents in this class: 47
10-year publication summary
|
2
|
5
|
1
|
3
|
1
|
2
|
5
|
3
|
4
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17639 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2535 |
4 |
| Universitat de Valencia | 220 |
3 |
| Bayer Cropscience AG | 2138 |
2 |
| FUJIFILM Corporation | 28805 |
2 |
| Biotix, Inc. | 181 |
2 |
| The Brigham and Women's Hospital, Inc. | 2142 |
2 |
| Rohm and Haas Electronic Materials Korea Ltd. | 330 |
2 |
| Huen Co.,Ltd. | 5 |
2 |
| Klotho Sciences | 7 |
2 |
| Samsung Display Co., Ltd. | 32798 |
1 |
| Boehringer Ingelheim International GmbH | 4754 |
1 |
| Chevron Oronite Company LLC | 560 |
1 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10692 |
1 |
| JSR Corporation | 2476 |
1 |
| Adeka Corporation | 1342 |
1 |
| China Pharmaceutical University | 274 |
1 |
| Enanta Pharmaceuticals, Inc. | 422 |
1 |
| Irm LLC | 187 |
1 |
| Presidio Pharmaceuticals, Inc. | 18 |
1 |
| Other owners | 12 |